Gen-Probe, a developer of nucleic acid probe-based products, has appointed Eric Lai as its new senior vice president of R&D.
Subscribe to our email newsletter
Dr La was most recently vice president of pharmacogenetics experimental project coordination and analysis, at GlaxoSmithKline.
Dr Lai has earned a PhD in pharmacology and microbiology from Columbia University, MPhil and MA degrees from the department of pharmacology at Columbia, and a BS in chemistry from the University of Waterloo in Ontario, Canada.
Carl Hull, president and COO of Gen-Probe, said: “We are very pleased to add Eric’s scientific expertise and leadership to our already strong senior management team. We believe Eric will play an integral role in helping our R&D team drive short-, medium- and long-term product sales growth for the company.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.